Cambria Investment Management, L.P. My Md Pharmaceuticals, Inc. Transaction History

Cambria Investment Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.47 - $1.87 $52,327 - $208,196	111,335 Added 184.83%	171,570 $101,000
Q2 2023 Aug 10, 2023	SELL	$1.44 - $2.26 $2,478 - $3,889	-1,721 Reduced 2.78%	60,235 $90,000
Q1 2023 May 11, 2023	SELL	$1.1 - $2.86 $7,572 - $19,688	-6,884 Reduced 10.0%	61,956 $106,000
Q4 2022 Feb 13, 2023	BUY	$0.92 - $96.0 $3,166 - $330,432	3,442 Added 5.26%	68,840 $79,000
Q3 2022 Nov 08, 2022	BUY	$2.22 - $82.2 $145,183 - $5.38 Million	65,398 New	65,398 $171,000

30.2K

Ticker MYMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,470,000
Market Cap $67.5M
Description
MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and o...

Get notified when there are updates to the investment portfolio of Cambria Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Cambria Investment Management, L.P. with notifications on news.